# A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants

> **NCT05757531** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 7 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [¹⁴C]-LY3437943

## Key facts

- **NCT ID:** NCT05757531
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-17
- **Primary completion:** 2023-06-23
- **Final completion:** 2023-06-23
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05757531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05757531, "A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05757531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*